期刊文献+

突变的SOD1 cDNA与人MAP/MARK1片段在人胚肾293细胞中的相互作用

Interaction between mutated SOD1 cDNA and segment of Homo sapiens MAP/MARK1 in human embryonic kidney cell 293
下载PDF
导出
摘要 目的用酵母双杂交方法显示突变的SOD1cDNA与人MAP/MARK1的片段结合,进一步探讨二者能否在哺乳动物表达系统人胚肾293细胞中发生相互作用,以验证酵母双杂交的结果。方法采用PCR方法及双酶切的方法构建含突变SOD1cDNA片段的真核表达质粒pCMV-Myc和含人MAP/MARK1的片段真核表达质粒pCMV-HA,分别或共同转染人胚肾293细胞,进行免疫共沉淀检测。结果免疫共沉淀结果表明,重组含突变的SOD1cDNA质粒pCMV-Myc分别与空载体pCMV-Myc、pCMV-HA共转染,免疫沉淀物中均未检测到结合蛋白,只有重组含突变SOD1cDNA真核表达质粒pCMV-Myc与重组含人MAP/MARK1的片段真核表达质粒pCMV-HA共转染时,在免疫沉淀物中能检测到结合蛋白,表现在蛋白免疫印迹上有特异性目的条带。结论突变的SOD1cDNA与人MAP/MARK1片段在人胚肾293细胞中存在蛋白水平的相互作用。 Objective By using yeast two-hybrid system, an interaction is proven existing between mutated SOD1 cDNA and segment of Homo sapiens MAP/MARK1. In the present study the interaction between the two proteins was further determined in human embryonic kidney cell 293 ( HEK293 ) to verify the results of yeast two-hybrid system. Methods Mammalian expression vectors pCMV-Myc containing mutated SOD1 cDNA and pCMV-HA containing segments of Homo sapiens MAP/MARK1 were constructed by PCR and double enzyme digestion. They were transfected to HEK293 cells and examined by coimmunoprecipitation. Results The coimmunoprecipitation experiments showed when the recombinated plasmid pCMV-Myc with mutated SOD1 cDNA was cotransfected with plasmid pCMV-Myc or plasmid pCMV-HA, there was no binding protein observed in HEK293 cells. However, when the recombinated plasmid pCMV-Myc with mutated SOD1 cDNA and recombinated plasmid pCMV-HA with segment of Homo sapiens MAP/MARK1 were cotransfected into HEK293 cells, the binding protein was detected. Conclusion The mutated SOD1 cDNA interacts with segment of Homo sapiens MAP/MARK1 at protein level in HEK293 cells.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2007年第24期2327-2329,共3页 Journal of Third Military Medical University
基金 国家自然科学基金(30300116)~~
关键词 突变SOD1 CDNA 人MAP/MARK1 免疫共沉淀 相互作用 mutated SOD1 cDNA Homo sapiens MAP/MARK1 coimmunoprecipitation interaction
  • 相关文献

参考文献12

  • 1Bradley M, Bradley L, de-Belleroche J, et al. Patterns of inheritance in familial ALS [Jl. Neurology, 2005, 64(9): 1628- 1631.
  • 2Jacobsson J, Jonsson P A, Andersen P M, et al. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations[ J ]. Brain, 2001, 124 ( Pt 7 ) : 1461 - 1466.
  • 3史树贵,李露斯,陈康宁,刘昕.一个肌萎缩侧索硬化家系的SOD1基因突变[J].中华医学遗传学杂志,2004,21(2):149-152. 被引量:19
  • 4胡俊,李露斯,吴玉章,倪兵,史树贵.构建具有突变铜-锌超氧化物歧化酶绿色荧光真核表达载体[J].中国临床康复,2005,9(29):58-59. 被引量:2
  • 5史树贵,李露斯,刘昕,倪兵,陈康宁.一个肌萎缩侧索硬化家系D21S223微卫星位点遗传连锁分析[J].第三军医大学学报,2006,28(4):363-365. 被引量:2
  • 6Bolduc N, Ouellet M, Pitre F, et al. Molecular characterization of two plant BI-1 homologues which suppress Bax-induced apoptosis in human 293 cells[J]. Planta, 2003, 216(3): 377 -386.
  • 7Vicentic A, Robeva A, Rogge G, et al. Biochemistry and pharmacology of epitope-tagged alpha ( 1 )-adrenergic receptor subtypes [ J ]. J Pharmacol Exp Ther, 2002, 302 ( 1 ) : 58 - 65.
  • 8Garrigue-Antar L, Hartigan N, Kadler K E. Post-translational modification of bone morphogenetic protein-I is required for secretion and stability of the protein [ J ]. J Biol Chem, 2002, 277 (45) : 43327 - 43334.
  • 9Panneerselvam S, Marx A, Mandelkow E M, et al. Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/ Par-1 [J]. Structure, 2006, 14(2) : 173 - 183.
  • 10Ferrer I. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease [ J ]. Cerebellum, 2002, 1 (3) : 213 - 222.

二级参考文献24

  • 1史树贵,李露斯,陈康宁,刘昕.一个肌萎缩侧索硬化家系的SOD1基因突变[J].中华医学遗传学杂志,2004,21(2):149-152. 被引量:19
  • 2ROWLAND L P.Hereditary and acquired motor neuron diseases[M]// ROWLAND L P.Merritt′ textbook of neurology[M].Philadelphia:Williams & Wilkins,1995:742-749.
  • 3ROSEN D R,SIDDIQUE T,PATTERSON D,et al.Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis[J].Nature,1993,362(6415):59-62.
  • 4ABE K,AOKI M,IKEDA M,et al.Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations[J].J Neurol Sci,1996,136(1-2):108-116.
  • 5BROOKS B R.El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis.Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical Limits of Amyotrophic Lateral Sclerosis" workshop contributors[J].J Neurol Sci,1994,124(Supp l):96-107.
  • 6SIDDIQUE T,FIGLEWICZ D A,PERICAK VANCE M A,et al.Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity[J].N Engl J Med,1991,324(20):1381-1384.
  • 7OHI T,SAITA K,TAKECHI S,et al.Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase[J].J Neurol Sci,2002,197(1-2):73-78.
  • 8KIM N H,KIM H J,KIM M,et al.A novel SOD1 gene mutation in a Korean family with amyotrophic lateral sclerosis[J].J Neurol Sci,2003,206(1):65-69.
  • 9Orrell RW, Habgood JJ, Gardiner I, et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurolog
  • 10Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 362∶59-62.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部